Voltaren and Radiculopathy - a phase IV clinical study of FDA data
Summary:
Radiculopathy is reported as a side effect among people who take Voltaren (diclofenac sodium), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Celebrex, and have Psoriatic arthropathy.
The phase IV clinical study analyzes which people have Radiculopathy when taking Voltaren. It is created by eHealthMe based on reports of 81,356 people who have side effects when taking Voltaren from the FDA, and is updated regularly.
What is Voltaren?
Voltaren has active ingredients of diclofenac sodium. It is often used in arthritis. eHealthMe is studying from 82,346 Voltaren users. Check the latest studies of Voltaren.
What is Radiculopathy?
Radiculopathy (a set of conditions in which one or more nerves is affected and does not work properly) is found to be associated with 739 drugs and 608 conditions by eHealthMe. Check the latest studies of Radiculopathy.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
81,356 people reported to have side effects when taking Voltaren.
Among them, 39 people (0.05%) have Radiculopathy.

Among these 39 people:
How long have people been on Voltaren when they have Radiculopathy? *
- < 1 month: 100 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Radiculopathy when taking Voltaren? *
- female: 47.22 %
- male: 52.78 %
What is the age of people who have Radiculopathy when taking Voltaren? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 7.69 %
- 40-49: 7.69 %
- 50-59: 26.92 %
- 60+: 57.69 %
What are other drugs people take besides Voltaren? *
- Celebrex: 20 people, 51.28%
- Methotrexate: 10 people, 25.64%
- Prednisone: 10 people, 25.64%
- Prilosec: 10 people, 25.64%
- Cosentyx: 10 people, 25.64%
- Sulfasalazine: 9 people, 23.08%
- Ibuprofen: 8 people, 20.51%
- Lasix: 8 people, 20.51%
- Lipitor: 8 people, 20.51%
- Erelzi: 8 people, 20.51%
What are other side effects people have besides Radiculopathy? *
- Fatigue (feeling of tiredness): 21 people, 53.85%
- Pain In Extremity: 20 people, 51.28%
- Weakness: 19 people, 48.72%
- Nausea (feeling of having an urge to vomit): 19 people, 48.72%
- Dyspnea (difficult or laboured breathing): 18 people, 46.15%
- Headache (pain in head): 17 people, 43.59%
- Cough: 17 people, 43.59%
- Sciatica (a set of symptoms including pain caused by general compression or irritation of one of five spinal nerve roots of each sciatic nerve): 16 people, 41.03%
- Intervertebral Disc Protrusion (spinal disc protrusion): 15 people, 38.46%
- Depression: 13 people, 33.33%
What are the existing conditions these people have? *
- Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 11 people, 28.21%
- Ankylosing Spondylitis (type of arthritis affecting the spine): 8 people, 20.51%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 8 people, 20.51%
- Gravitational Oedema (abnormally large fluid volume in the circulatory system makes obese): 7 people, 17.95%
- Hyperlipidaemia (presence of excess lipids in the blood): 7 people, 17.95%
- Osteoporosis (bones weak and more likely to break): 7 people, 17.95%
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 7.69%
- Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 2 people, 5.13%
- Breast Cancer Metastatic: 2 people, 5.13%
- Cataplexy (loss of muscle tone accompanied by full conscious awareness): 2 people, 5.13%
* Approximation only. Some reports may have incomplete information.
Do you take Voltaren and have Radiculopathy?
- Check whether Radiculopathy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Voltaren:
- Voltaren (82,346 reports)
Radiculopathy treatments and more:
- Radiculopathy (5,655 reports)
How severe was Radiculopathy and when was it recovered:
Expand to all the drugs that have ingredients of diclofenac sodium:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Voltaren:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Radiculopathy:
- Radiculopathy (739 drugs)
Browse all the conditions that are associated with Radiculopathy:
- Radiculopathy (608 conditions)
Related publications that referenced our studies
- Foroughipour M, Farzadfard MT, Aghaee M, Ghabeli-Juibary A, Rezaietalab F, "Methamphetamine Related Radiculopathy: Case Series and Review of Literature", Asia Pacific Journal of Medical Toxicology, 2013 Jun .
- Foroughipour M, Farzadfard MT, Aghaee M, Ghabeli-Juibary A, Rezaietalab F, "Methamphetamine Related Radiculopathy: Case Series and Review of Literature", Asia Pacific Journal of Medical Toxicology, 2013 Jun .
How the study uses the data?
The study uses data from the FDA. It is based on diclofenac sodium (the active ingredients of Voltaren) and Voltaren (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Ribavirin cause Urosepsis? - 2 seconds ago
- Could Faslodex cause Blood Creatinine Increased? - 3 seconds ago
- Drug interactions of Vitamin C and Tinidazole - 4 seconds ago
- Could Olmetec cause Upper Gastrointestinal Haemorrhage? - 4 seconds ago
- Could Olmesartan Medoxomil cause Gallstones? - 7 seconds ago
- Movicol vs. Dulcolax, side effect and effectiveness comparison - 12 seconds ago
- Could Sudafed cause Failure To Thrive? - 15 seconds ago
- Could Kytril cause Cuts And Puncture Wounds? - 16 seconds ago
- Could Propecia cause Hyperthyroidism? - 17 seconds ago
- Could Xanax cause Migraine? - 17 seconds ago